ARTICLE | Clinical News
Product R: Began Phase I trial
September 10, 2001 7:00 AM UTC
Advanced Viral Research Corp. (ADVR), Yonkers, N.Y. Product: Product R Business: Infectious diseases Therapeutic category: Immune modulation Target: Immune cells Description: Topical peptide nucleic...